Rapid Micro Biosystems (RPID) Operating Leases (2022 - 2026)

Rapid Micro Biosystems (RPID) has 5 years of Operating Leases data on file, last reported at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 28.1% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 28.1% YoY), and the FY2025 full-year result was $3.7 million, down 25.84% from the prior year.
• Operating Leases declined to $3.3 million in Q1 2026, from $3.7 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $7.7 million in Q2 2022 to a low of $1.3 million in Q1 2022.
• A 5-year average of $5.4 million and a median of $5.6 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases soared 433.85% in 2023 and fell 28.1% in 2026, its largest moves.
• Tracing RPID's Operating Leases over 5 years: stood at $7.2 million in 2022, then retreated by 13.72% to $6.2 million in 2023, then dropped by 20.28% to $5.0 million in 2024, then decreased by 25.84% to $3.7 million in 2025, then fell by 9.17% to $3.3 million in 2026.
• Business Quant data shows RPID's Operating Leases at $3.3 million in Q1 2026, $3.7 million in Q4 2025, and $4.0 million in Q3 2025.